Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eliquis
Pharma
BMS turns focus to new growth drivers as legacy meds decline
The majority of Bristol Myers Squibb's $48.2 billion revenue haul in 2025 came from its collection of newer growth products.
Zoey Becker
Feb 5, 2026 11:45am
BMS, Pfizer to provide discounted Eliquis through online program
Jul 17, 2025 10:59am
After $1.5B cost-cutting plan, BMS will cut an additional $2B
Feb 6, 2025 8:33am
BMS cuts 195 jobs, bringing head count reduction to 1,329 in NJ
Nov 25, 2024 12:59pm
Pfizer cranks up 2024 revenue outlook by $1B
Jul 30, 2024 12:20pm
CEO says BMS can handle impact of IRA price negotiation
Jul 26, 2024 11:36am
